Release and pharmacokinetics of near-infrared labeled albumin from monodisperse poly(d,l-lactic-co-hydroxymethyl glycolic acid) microspheres after subcapsular renal injection
Source abstract
Abstract
Subcapsular renal injection is a novel administration method for local delivery of therapeutics for the treatment of kidney related diseases. The aim of this study was to investigate the feasibility of polymeric microspheres for sustained release of protein therapeutics in the kidney and study the subsequent redistribution of the released protein. For this purpose, monodisperse poly(d,l-lactic-co-hydroxymethyl glycolic acid) (PLHMGA) microspheres (40 μm in diameter) loaded with near-infrared dye-labeled bovine serum albumin (NIR-BSA) were prepared by a membrane emulsification method. Rats were injected with either free NIR-BSA or with NIR-BSA loaded microspheres (NIR-BSA-ms) and the pharmacokinetics of the released NIR-BSA was studied for 3 weeks by ex vivo imaging of organs and blood. Quantitative release data were obtained from kidney homogenates and possible metabolism of the protein was investigated by SDS-PAGE analysis of the samples. The ex vivo images showed a rapid decrease of the NIR signal within 24h in kidneys injected with free NIR-BSA, while, importantly, the signal of the labeled protein was still visible at day 21 in kidneys injected with NIR-BSA-ms. SDS-PAGE analysis of the kidney homogenates showed that intact NIR-BSA was released from the microspheres. The locally released NIR-BSA drained to the systemic circulation and subsequently accumulated in the liver, where it was degraded and excreted renally. The in vivo release of NIR-BSA was calculated after extracting the protein from the remaining microspheres in kidney homogenates. The in vivo release rate was faster (89 ± 4% of the loading in 2 weeks) compared to the in vitro release of NIR-BSA (38 ± 1% in 2 weeks). In conclusion, PLHMGA microspheres injected under the kidney capsule provide a local depot from which a formulated protein is released over a prolonged time-period.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Biomedical Research and Pathophysiology · Urinary Bladder and Prostate Research · Dialysis and Renal Disease Management
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (54)
Show source-provided references
1. Treatment of acute renal failure10.1046/j.1523-1755.1998.00210.x ↗
2. Inflammation in chronic kidney disease: role in the progression of renal and cardiovascular disease10.1007/s00467-008-1046-0 ↗
3. Immunologic function and survival in hemodialysis patients10.1046/j.1523-1755.1998.00981.x ↗
4. The progression of renal disease10.1056/NEJM198806233182505 ↗
5. Glycoxidation and inflammation in renal failure patients10.1053/j.ajkd.2003.11.022 ↗
6. Novel targets of antifibrotic and anti-inflammatory treatment in CKD10.1038/nrneph.2014.31 ↗
7. The non-haematopoietic biological effects of erythropoietin10.1111/j.1365-2141.2008.07014.x ↗
8. Interleukin-10 therapy – review of a new approach10.1124/pr.55.2.4 ↗
9. Interferon-γ improves renal interstitial fibrosis and decreases intrarenal vascular resistance of hydronephrosis in an animal model10.1016/j.urology.2010.10.015 ↗
10. Bone morphogenic protein-7 and the kidney: current concepts and open questions10.1093/ndt/gfk010 ↗
11. Next-generation protein drugs10.1038/nbt0504-521 ↗
12. Delivery of therapeutic proteins10.1002/jps.22054 ↗
13. Why and how to prepare biodegradable, monodispersed, polymeric microparticles in the filed of pharmacy?10.1016/j.ijpharm.2011.01.027 ↗
14. Overcoming the challenges in administering biopharmaceuticals: formulation and delivery strategies10.1038/nrd4363 ↗
15. Contribution of intrarenal cells to cellular repair after acute kidney injury: subcapsular implantation technique10.1152/ajprenal.90205.2008 ↗
16. Development and in-vivo characterization of supramolecular hydrogels for intrarenal drug delivery10.1016/j.biomaterials.2012.03.052 ↗
17. Hierarchical formation of supramolecular transient networks in water: a modular injectable delivery system10.1002/adma.201104072 ↗
18. Biocompatibility of poly(d,l-lactic-co-hydroxymethyl glycolic acid) microspheres after subcutaneous and subcapsular renal injection10.1016/j.ijpharm.2014.12.014 ↗
19. Local therapeutic efficacy with reduced systemic side effects by rapamycin-loaded subcapsular microspheres10.1016/j.biomaterials.2014.11.042 ↗
20. Hydrophilic polyester microspheres: effect of molecular weight and copolymer composition on release of BSA10.1007/s11095-010-0205-8 ↗
21. Preparation and characterization of protein loaded microspheres based on a hydroxylated aliphatic polyester, poly(lactic-co-hydroxymethyl glycolic acid)10.1016/j.jconrel.2009.04.025 ↗
22. The microclimate pH in poly(d,l-lactide-co-hydroxymethyl glycolide) microspheres during biodegradation10.1016/j.biomaterials.2012.06.013 ↗
23. Functional aliphatic polyesters for biomedical and pharmaceutical applications10.1016/j.jconrel.2010.12.016 ↗
24. Computer modeling assisted design of monodisperse PLGA microspheres with controlled porosity affords zero order release of an encapsulated macromolecule for 3months10.1007/s11095-014-1381-8 ↗
25. Membrane emulsification by microporous glass
26. In vivo near-infrared fluorescence imaging10.1016/j.cbpa.2003.08.007 ↗
27. Functionalized poly(a-hydroxy acid)s via ring-opening polymerization: toward hydrophilic polyesters with pendant hydroxyl groups10.1021/ma052128c ↗
28. Serum albumin
29. Particle control of emulsion by membrane emulsification and its applications10.1016/S0169-409X(00)00099-5 ↗
30. A new strategy to determine the actual protein content of poly(lactide-co-glycolide) microspheres10.1021/js960363q ↗
31. Physicochemical studies on indocyanine green: molar lineic absorbance, pH tolerance, activation energy and rate of decay in various solvents
32. A novel method to quantify IRDye800CW fluorescent antibody probes ex vivo in tissue distribution studies10.1186/2191-219X-2-50 ↗
33. Biodegradable microspheres loaded with an anti-Parkinson prodrug: an in vivo pharmacokinetic study10.1021/mp200337h ↗
34. In vitro and in vivo correlation of buserelin release from biodegradable implants using statistical moment analysis10.1016/j.jconrel.2003.09.003 ↗
35. Preparation and characterization of protein loaded microspheres based on a hydroxylated aliphatic polyester, poly(lactic-co-hydroxymethyl glycolic acid)10.1016/j.jconrel.2009.04.025 ↗
36. Mechanistic studies on the degradation and protein release characteristics of poly(lactic-co-glycolic-co-hydroxymethylglycolic acid) nanospheres10.1021/bm301900t ↗
37. Nanocolloidal albumin-IRDye 800CW: a near-infrared fluorescent tracer with optimal retention in the sentinel lymph node10.1007/s00259-012-2080-5 ↗
38. Pre-clinical whole-body fluorescence imaging: review of instruments, methods and applications10.1016/j.jphotobiol.2009.11.007 ↗
39. Functional renal imaging: new trends in radiology and nuclear medicine10.1053/j.semnuclmed.2010.08.003 ↗
40. Molecular imaging strategies for drug discovery and development10.1016/j.cbpa.2006.06.028 ↗
41. Rapid visualization of human tumor xenografts through optical imaging with a near-infrared fluorescent anti-epidermal growth factor receptor nanobody10.2310/7290.2011.00025 ↗
42. Noninvasive optical imaging of nanomedicine biodistribution10.1021/nn303955n ↗
43. Manufacture of IRDye800CW-coupled Fe3O4 nanoparticles and their applications in cell labeling and in vivo imaging10.1186/1477-3155-8-25 ↗
44. Combination of cell delivery and thermoinducible transcription for in vivo spatiotemporal control of gene expression: a feasibility study10.1148/radiol.10100767 ↗
45. Quantitative whole body biodistribution of fluorescent-labeled agents by non-invasive tomographic imaging10.1371/journal.pone.0020594 ↗
46. Comparison of in vitro and in vivo protein release from hydrogel systems10.1016/j.jconrel.2012.05.049 ↗
47. Raman imaging of PLGA microsphere degradation inside macrophages10.1021/ja0459936 ↗
48. Hydrophilic poly(dl-lactide-co-glycolide) microspheres for the delivery of DNA to human-derived macrophages and dendritic cells10.1016/S0168-3659(01)00413-8 ↗
49. Assessment of protein release kinetics, stability and protein polymer interaction of lysozyme encapsulated poly(d,l-lactide-co-glycolide) microspheres10.1016/S0168-3659(01)00533-8 ↗
50. Single-dose intravenous toxicity study of IRDye 800CW in sprague-dawley Rats10.1007/s11307-010-0317-x ↗
51. Real-time intraoperative ureteral guidance using invisible near-infrared fluorescence10.1016/j.juro.2007.06.049 ↗
52. Regulation of albumin metabolism10.1146/annurev.me.26.020175.000515 ↗
53. Degradation of serum albumin by rat liver and kidney lysosomes10.3177/jnsv.44.641 ↗
54. Uptake and degradation of formaldehyde-treated 125I-labelled human serum albumin in rat liver cells in vivo and in vitro10.1016/0304-4165(77)90150-7 ↗